Preemptive vs prophylactic therapy for CMV disease prevention

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1630-1631, 2008-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prophylactic antivirals prevent CMV disease in transplant recipients

Inpharma, Vol. 1, Iss. 1492, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Pre-emptive ganciclovir preferred for CMV disease after kidney transplant

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 273, 2000-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Prevention of graft-vs.-host disease

By Rezvani Andrew R Storb Rainer F

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 12, 2012-08 ,pp. : 1737-1750

Informa Healthcare

Access to resources Recommend Favorite

Prophylactic, empirical, pre-emptive and targeted antibacterial therapy all play a role in invasive aspergillosis

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 25, Iss. 1, 2009-01 ,pp. : 18-22

Adis International

Access to resources Recommend Favorite

A 3-Year Follow-Up of Pre-Emptive vs Deferred Treatment of Cytomegalovirus Disease in Renal Transplantation

By Brennan D.C.

Clinical Drug Investigation, Vol. 19, Iss. 5, 2000-05 ,pp. : 367-374

Adis International

Access to resources Recommend Favorite